Genmab AS Stock Forecast - Coefficient Of Variation

GMAB Stock  DKK 2,030  24.00  1.20%   
Genmab Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Genmab AS stock prices and determine the direction of Genmab AS's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Genmab AS's historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of Genmab AS to cross-verify your projections.
To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.
  
Genmab AS has current Coefficient Of Variation of 0.
Most investors in Genmab AS cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Genmab AS's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Genmab AS's price structures and extracts relationships that further increase the generated results' accuracy.
Check Genmab AS VolatilityBacktest Genmab ASInformation Ratio  

Genmab AS Trading Date Momentum

On April 23 2024 Genmab AS was traded for  2,030  at the closing time. The highest price during the trading period was 2,047  and the lowest recorded bid was listed for  1,993 . There was no trading activity during the period 0.0. Lack of trading volume on April 23, 2024 did not cause price change. The overall trading delta to the current price is 0.64% .
Compare Genmab AS to competition

Other Forecasting Options for Genmab AS

For every potential investor in Genmab, whether a beginner or expert, Genmab AS's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Genmab Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Genmab. Basic forecasting techniques help filter out the noise by identifying Genmab AS's price trends.

Genmab AS Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genmab AS stock to make a market-neutral strategy. Peer analysis of Genmab AS could also be used in its relative valuation, which is a method of valuing Genmab AS by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Genmab AS Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Genmab AS's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Genmab AS's current price.

Genmab AS Market Strength Events

Market strength indicators help investors to evaluate how Genmab AS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genmab AS shares will generate the highest return on investment. By undertsting and applying Genmab AS stock market strength indicators, traders can identify Genmab AS entry and exit signals to maximize returns.

Genmab AS Risk Indicators

The analysis of Genmab AS's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Genmab AS's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting genmab stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:
Check out Historical Fundamental Analysis of Genmab AS to cross-verify your projections.
To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Genmab Stock analysis

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genmab AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.